SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-151913
Filing Date
2022-05-16
Accepted
2022-05-16 16:49:46
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d714983ds3.htm S-3 393997
2 EX-1.2 d714983dex12.htm EX-1.2 175301
3 EX-4.3 d714983dex43.htm EX-4.3 30544
4 EX-4.4 d714983dex44.htm EX-4.4 311129
5 EX-5.1 d714983dex51.htm EX-5.1 35495
6 EX-23.1 d714983dex231.htm EX-23.1 1665
7 EX-FILING FEES d714983dexfilingfees.htm EX-FILING FEES 32674
8 GRAPHIC g714983g04b35.jpg GRAPHIC 62160
9 GRAPHIC g714983g30y77.gif GRAPHIC 4326
10 GRAPHIC g714983g34x93.jpg GRAPHIC 86508
  Complete submission text file 0001193125-22-151913.txt   1183923
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: S-3 | Act: 33 | File No.: 333-264987 | Film No.: 22930327
SIC: 2834 Pharmaceutical Preparations